Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections
Data up to Jan 2025
Total Citations Per Year
Abstract
References (41)
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
1987 • 2,492 citations
Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin
1985 • 2,380 citations
Detection of Circulating Tumor Necrosis Factor after Endotoxin Administration
1988 • 1,711 citations
Surgery, Gynecology and obstetrics.
2012 • 1,562 citations
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
1989 • 1,183 citations
ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE
1987 • 1,108 citations
The Cardiovascular Response of Normal Humans to the Administration of Endotoxin
1989 • 1,096 citations
Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
1988 • 990 citations
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
1990 • 865 citations
Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.
1992 • 842 citations
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
1992 • 832 citations
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity
1992 • 799 citations
Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever
1990 • 765 citations
Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious Purpura
1988 • 735 citations
Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects
1990 • 681 citations
Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.
1991 • 589 citations
Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock
1990 • 555 citations
Cytokine appearance in human endotoxemia and primate bacteremia.
1988 • 528 citations
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trial
1994 • 488 citations
Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans
1989 • 485 citations
The Proinflammatory Cytokines Interleukin-l and Tumor Necrosis Factor and Treatment of the Septic Shock Syndrome
1991 • 409 citations
Plasma Tumor Necrosis Factor in Patients with Septic Shock: Mortality Rate, Incidence of Adult Respiratory Distress Syndrome, and Effects of Methylprednisolone Administration
1990 • 335 citations
Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.
1992 • 324 citations
Plasma tumor necrosis factor and mortality in critically ill septic patients
1989 • 324 citations
Production of interleukin-1-receptor antagonist during experimental endotoxaemia
1991 • 311 citations
A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice.
1991 • 298 citations
Production of tumor necrosis factor during murine listeriosis.
1987 • 241 citations
Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer.
1987 • 216 citations
Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.
1992 • 203 citations
Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated
1991 • 201 citations
Influence of nephrectomy on tumor necrosis factor clearance in a murine model.
1993 • 182 citations
Differential Expression of Proinflammatory Cytokines and Their Inhibitors during the Course of Meningococcal Infections
1994 • 175 citations
Cytokines and the response to infection
1992 • 162 citations
Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange.
1984 • 149 citations
Protective Effects of Tumor Necrosis Factor in Experimental Legionella pneumophila Infections of Mice via Activation of PMN Function
1988 • 133 citations
PLASMA AND WHOLE BLOOD EXCHANGE IN MENINGOCOCCAL SEPSIS
1993 • 100 citations
Soluble and cell surface receptors for tumor necrosis factor
1992 • 66 citations
Involvement of tumor necrosis factor alpha in intracellular multiplication of Legionella pneumophila in human monocytes
1993 • 45 citations
Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock
1992 • 42 citations
A tumor necrosis factor binding protein (TNF-BP)-physiological antagonist of TNF
1991 • 7 citations
INCIDENCE AND CONSEQUENCES OF MULTIPLE ORGAN DYSFUNCTION SYNDROME AFTER ABDOMINAL AORTIC RECONSTRUCTION
1994 • 6 citations